Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122.8 USD | +1.47% | -1.58% | -2.46% |
16/05 | Morgan Stanley Adjusts Ascendis Pharma Price Target to $140 From $116, Maintains Equal Weight Rating | MT |
14/05 | US Equity Markets Close Higher Tuesday as Producer Prices Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.46% | 6.94B | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Credit Suisse Downgrades Ascendis Pharma to Neutral From Outperform, Lowers Price Target to $82 From $130